Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BAX Baxter International Inc. daily Stock Chart
BAX [NYSE]
Baxter International Inc.
Healthcare | Medical Instruments & Supplies | USA
financial highlights | statements
IndexS&P 500 P/E24.58 EPS (ttm)2.99 Insider Own0.10% Shs Outstand534.00M Perf Week2.70%
Market Cap39.21B Forward P/E19.70 EPS next Y3.73 Insider Trans-93.83% Shs Float531.67M Perf Month7.57%
Income1.63B PEG2.26 EPS next Q0.68 Inst Own85.00% Short Float0.98% Perf Quarter16.50%
Sales11.13B P/S3.52 EPS this Y-73.80% Inst Trans-2.14% Short Ratio1.33 Perf Half Y3.06%
Book/sh17.10 P/B4.29 EPS next Y13.63% ROA5.40% Target Price78.53 Perf Year11.21%
Cash/sh5.36 P/C13.71 EPS next 5Y10.90% ROE10.10% 52W Range61.05 - 78.38 Perf YTD11.56%
Dividend0.76 P/FCF40.93 EPS past 5Y-10.50% ROI10.90% 52W High-6.32% Beta1.02
Dividend %1.03% Quick Ratio2.00 Sales past 5Y-5.40% Gross Margin43.20% 52W Low20.28% ATR1.04
Employees47000 Current Ratio2.60 Sales Q/Q2.20% Oper. Margin13.20% RSI (14)69.20 Volatility0.80% 1.44%
OptionableYes Debt/Eq0.38 EPS Q/Q123.80% Profit Margin8.20% Rel Volume0.61 Prev Close72.44
ShortableYes LT Debt/Eq0.38 EarningsJan 31 BMO Payout39.60% Avg Volume3.92M Price73.43
Recom1.90 SMA203.10% SMA508.09% SMA2003.57% Volume2,373,716 Change1.37%
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-02-19Upgrade Citigroup Neutral → Buy
Nov-02-18Upgrade Argus Hold → Buy
Oct-16-18Initiated Barclays Underweight $73
May-17-18Resumed Piper Jaffray Overweight $77
Feb-06-18Reiterated Citigroup Neutral $66 → $70
Jan-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Jan-02-18Upgrade BofA/Merrill Neutral → Buy
Aug-17-17Initiated Citigroup Neutral $63
Jul-28-17Reiterated UBS Neutral $57 → $62
Jul-27-17Reiterated Barclays Overweight $64 → $70
Jun-30-17Initiated Cantor Fitzgerald Overweight $70
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $55 → $58
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Feb-16-19 08:40AM  Does Baxter International Inc. (NYSE:BAX) Have A Good P/E Ratio? Simply Wall St.
Feb-14-19 09:07AM  Baxter's Acute Therapies Profile Strong, Competition Rife Zacks
Feb-13-19 04:15PM  Baxter to Present at the Barclays Global Healthcare Conference Business Wire
Feb-11-19 08:00AM  Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU Business Wire
Feb-06-19 04:15PM  Baxter to Present at the Raymond James 40th Annual Institutional Investors Conference Business Wire
Feb-05-19 01:21PM  Affiliate of Charlotte-based Premier partners with Baxter to make generic drugs more available American City Business Journals
Feb-04-19 07:47PM  [$$] Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture The Wall Street Journal
06:02PM  [$$] Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture The Wall Street Journal
07:25AM  Report: Developing Opportunities within Ensco plc, Third Point Reinsurance, Baxter International, Ultrapar Participacoes S.A, Endeavour Silver, and Ingles Markets Future Expectations, Projections Moving into 2019 GlobeNewswire
Feb-01-19 09:20AM  Edited Transcript of BAX earnings conference call or presentation 31-Jan-19 1:30pm GMT Thomson Reuters StreetEvents
Jan-31-19 05:53PM  Baxter (BAX) Q4 2018 Earnings Conference Call Transcript Motley Fool
11:42AM  Baxter's (BAX) Earnings, Revenues Beat Estimates in Q4 Zacks
08:40AM  Baxter International (BAX) Q4 Earnings and Revenues Surpass Estimates Zacks
08:24AM  Baxter: 4Q Earnings Snapshot Associated Press
07:15AM  Baxter Reports 2018 Fourth-Quarter and Full-Year Results Business Wire
06:21AM  Before Investing In Baxter International Inc. (NYSE:BAX), Consider This Simply Wall St.
Jan-30-19 01:44PM  Health care giant Baxter to grow Glendale company's medical software American City Business Journals
09:02AM  Medical Products' Earnings Lineup for Jan 31: EW, BAX & More Zacks
Jan-29-19 06:01PM  Baxter to Present at the 8th Annual SVB Leerink Global Healthcare Conference Business Wire
Jan-28-19 07:55AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings? Zacks
Jan-24-19 06:02PM  Investors With Outsized Bets on One Stock: David Tepper and Daniel Loeb GuruFocus.com
10:31AM  Baxter International (BAX) Reports Next Week: Wall Street Expects Earnings Growth Zacks
09:56AM  Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings? Zacks
Jan-21-19 07:56AM  Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings? Zacks
Jan-18-19 09:44AM  Stock Market News For Jan 18, 2019 Zacks
08:02AM  Baxter (BAX) Gains From Sharesource's Global Success Rates Zacks
Jan-17-19 08:43PM  [$$] The shifting fortunes of art fairs Financial Times
08:30AM  Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management Business Wire
06:06AM  A Look At The Intrinsic Value Of Baxter International Inc. (NYSE:BAX) Simply Wall St.
Jan-15-19 08:56AM  Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings? Zacks
06:09AM  Varian Medical (VAR) to Report Q1 Earnings: What's in Store? Zacks
Jan-08-19 09:58AM  Stock Market News For Jan 8, 2019 Zacks
07:21AM  Baxter's PD Solution to Treat Patients, Prospects Bright Zacks
Jan-07-19 08:40AM  Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System Business Wire
Jan-03-19 10:10AM  Can Baxter (BAX) Keep the Earnings Surprise Streak Alive? Zacks
Jan-02-19 02:34PM  Morgan Stanley Finds A Few Reasons To Double Upgrade Baxter Benzinga
06:04AM  Read This Before Buying Baxter International Inc. (NYSE:BAX) For Its Dividend Simply Wall St.
Dec-31-18 03:11PM  6 Undervalued Stocks Growing Earnings GuruFocus.com
Dec-24-18 09:29AM  Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III Zacks
Dec-21-18 04:15PM  Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for Investors Business Wire
Dec-20-18 09:27AM  4 Stocks Respected Activist Investor Jeffrey Smith Bought in Q3 (and 1 He Dumped) Insider Monkey
07:20AM  New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Dec-19-18 02:46PM  Credit Suisse Initiates Coverage of Large Health Care Stocks GuruFocus.com
09:30AM  Stock Market News For Dec 19, 2018 Zacks
Dec-18-18 08:30AM  Baxter Launches Curved Applicator for Floseal, Expanding Use of Leading Hemostat During ENT Procedures Business Wire
Dec-16-18 08:35AM  At US$65.70, Is It Time To Put Baxter International Inc. (NYSE:BAX) On Your Watch List? Simply Wall St.
Dec-13-18 09:04AM  Here's Why You Should Hold Baxter International (BAX) Now Zacks
Dec-10-18 08:45AM  Baxter & EFCNI Collaborate to Improve Care for Preterm Born Zacks
Dec-08-18 10:20AM  Hedge Funds Are Still Crazy About Baxter International Inc. (BAX) Insider Monkey
Dec-06-18 05:32PM  Dan Loeb Sells Baxter International Shares at Strong Gain GuruFocus.com
04:30PM  Baxter Supports New EFCNI Standards in Newborn Care in Raising Awareness of Risks from Malnutrition Business Wire
08:15AM  Baxter Appoints Patricia Morrison and Amy Wendell to Its Board Business Wire
Dec-04-18 04:15PM  Baxter to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-01-18 08:18AM  Baxter International Inc (NYSE:BAX): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St.
Nov-28-18 04:32PM  MS Global Franchise Fund's Top 5 Buys in 3rd Quarter GuruFocus.com
Nov-15-18 10:02AM  Baxter (BAX) Launches Peri-Strips & Tisseel Prima, Shares Up Zacks
Nov-14-18 08:15AM  Baxter Unveils New Products at the ASMBS Obesity Week Meeting to Help Surgeons Overcome Challenges During Bariatric Surgery Business Wire
Nov-13-18 09:21AM  Baxter board approves $2 billion increase to share buyback authorization MarketWatch
09:15AM  Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization Business Wire
08:15AM  Baxter Highlights Data at ISPOR Europe 2018 on Clinical and Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding Business Wire
Nov-12-18 09:45PM  Edited Transcript of BAX earnings conference call or presentation 31-Oct-18 12:30pm GMT Thomson Reuters StreetEvents
10:46AM  52-Week Company Lows GuruFocus.com
08:15AM  Baxter Introduces New Tisseel Prima Syringe at 2018 American Association of Gynecologic Laparoscopists Meeting Business Wire
Nov-06-18 04:15PM  Baxter to Present at Citis 2018 Global Healthcare Conference Business Wire
Nov-05-18 10:33AM  52-Week Company Lows GuruFocus.com
Nov-02-18 12:03PM  Baxter International Breaks Its February/April Lows: Now What? TheStreet.com
07:20AM  Report: Developing Opportunities within Pulse Biosciences, Baxter International, FirstEnergy, Affiliated Managers Group, Baidu, and Shopify Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-01-18 09:53AM  Company News For Nov 1, 2018 Zacks
Oct-31-18 06:28PM  Baxter Earnings beat, Revenue misses In Q3 Investing.com -8.96%
02:23PM  Baxter International Inc (BAX) Q3 2018 Earnings Conference Call Transcript Motley Fool
11:22AM  Baxter (BAX) Earnings Beat, Revenues Lag Estimates in Q3 Zacks
11:06AM  Is Baxter International Incs (NYSE:BAX) 10% ROE Strong Compared To Its Industry? Simply Wall St.
08:40AM  Baxter International (BAX) Tops Q3 Earnings Estimates Zacks
07:35AM  Baxter: 3Q Earnings Snapshot Associated Press
07:15AM  Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018 Business Wire
Oct-30-18 09:40AM  Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More Zacks
Oct-29-18 04:15PM  Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies Are Advancing Dialysis Care across Modalities Business Wire
07:00AM  Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies Business Wire
Oct-25-18 08:15AM  Baxter Announces U.S. Regulatory Filing for PrisMax Acute Care System and Presentation of 15 Abstracts to Start ASN: Kidney Week 2018 Business Wire
Oct-23-18 10:54AM  Can Medication Delivery Unit Aid Baxter's (BAX) Q3 Earnings? Zacks
Oct-22-18 08:42AM  Medidata (MDSO) Tops Earnings & Revenue Estimates in Q3 Zacks
Oct-19-18 09:30AM  Has Baxter International (BAX) Outpaced Other Medical Stocks This Year? Zacks
09:30AM  BAX vs. BSX: Which Stock Should Value Investors Buy Now? Zacks
09:29AM  Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks
08:05AM  Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress Business Wire
Oct-17-18 11:57AM  Barclays Takes Action on Health Care Stocks GuruFocus.com
Oct-16-18 10:47AM  What's in Store for Cerner (CERN) This Earnings Season? Zacks
Oct-12-18 10:23AM  Cerner's Millennium Platform Integrated at McLaren Hospital Zacks
10:10AM  Can Baxter (BAX) Keep the Earnings Surprise Streak Alive? Zacks
Oct-11-18 09:20AM  Baxter & ASPEN Launch PN Tools to Boost Clinical Nutrition Zacks
09:00AM  Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Oct-10-18 08:00AM  Baxter and ASPEN Launch SmartPN Tools to Reinforce Appropriate Use of Parenteral Nutrition Business Wire
Oct-07-18 05:20AM  Suvretta Capital Managements Return, AUM, and Holdings Insider Monkey
Oct-05-18 09:58AM  Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International Zacks
Oct-04-18 04:15PM  Baxter to Present at the 27th Annual Credit Suisse Healthcare Conference Business Wire
10:28AM  Buy These 4 Efficient Stocks for Stellar Returns Zacks
Oct-03-18 07:31AM  Baxter Collaborates With Mayo Clinic to Open Renal Care Center Zacks
Oct-02-18 09:00AM  Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S. Business Wire
08:49AM  Baxter (BAX) Collaborates With USC CBC to Digitize Healthcare Zacks
Sep-28-18 08:13AM  Baxter Collaborates with University of Southern California Center for Body Computing to Advance Digital Health Solutions Business Wire
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STALLKAMP THOMAS TDirectorJan 18Sale70.003,187223,0909,418Jan 23 05:36 PM
FORSYTH JOHN DDirectorDec 13Option Exercise24.271,50036,40531,640Dec 17 04:18 PM
Shapazian Carole JDirectorDec 13Option Exercise39.834,110163,70113,958Dec 17 04:21 PM
Shapazian Carole JDirectorDec 13Sale66.694,110274,0969,848Dec 17 04:21 PM
FORSYTH JOHN DDirectorDec 13Sale67.021,500100,53030,140Dec 17 04:18 PM
Shapazian Carole JDirectorDec 03Option Exercise41.2311,749484,40821,597Dec 06 05:17 PM
Shapazian Carole JDirectorDec 03Sale68.4811,749804,5729,848Dec 06 05:17 PM
Third Point LLCDirectorDec 03Sale68.628,000,000548,960,00028,008,125Dec 04 05:12 PM
Accogli GiuseppeSVP, President, Global Bus.Sep 17Option Exercise42.5617,647751,13867,785Sep 19 05:42 PM
Eyre Brik VSVP, President, AmericasSep 17Option Exercise38.1871,6432,735,345137,005Sep 19 05:43 PM
Eyre Brik VSVP, President, AmericasSep 17Sale77.3178,0126,031,10858,993Sep 19 05:43 PM
Accogli GiuseppeSVP, President, Global Bus.Sep 17Sale77.2717,6471,363,58450,138Sep 19 05:42 PM
Shapazian Carole JDirectorAug 08Option Exercise37.505,400202,50015,248Aug 10 04:17 PM
Shapazian Carole JDirectorAug 08Sale72.975,400394,0389,848Aug 10 04:17 PM
Pleau ScottSVP, OperationsJul 10Option Exercise48.1310,686514,36430,899Jul 12 04:56 PM
Pleau ScottSVP, OperationsJul 10Sale75.0010,686801,45020,213Jul 12 04:56 PM
Pleau ScottSVP, OperationsJun 25Option Exercise46.1827,1971,255,95747,363Jun 27 05:26 PM
Pleau ScottSVP, OperationsJun 25Sale73.5727,1972,000,88320,166Jun 27 05:26 PM
Shapazian Carole JDirectorMay 22Option Exercise36.933,930145,13516,442May 23 05:33 PM
Eyre Brik VSVP, President, AmericasMay 22Option Exercise37.3825,000934,50090,115May 23 05:45 PM
Eyre Brik VSVP, President, AmericasMay 22Sale71.9625,0001,799,00065,115May 23 05:45 PM
Shapazian Carole JDirectorMay 22Sale71.796,594473,3839,848May 23 05:33 PM
Mason Jeanne KSVP, Human ResourcesMay 21Option Exercise28.2731,395887,537128,777May 23 05:43 PM
Mason Jeanne KSVP, Human ResourcesMay 21Sale72.0031,3952,260,44097,382May 23 05:43 PM
Eyre Brik VSVP, President, AmericasMay 15Option Exercise37.3820,000747,60085,115May 17 04:03 PM
Eyre Brik VSVP, President, AmericasMay 15Sale70.5720,0001,411,40065,115May 17 04:03 PM
STROUCKEN ALBERT P LDirectorApr 02Option Exercise33.773,760126,97528,380Apr 04 05:21 PM
HELLMAN PETER SDirectorApr 02Option Exercise33.773,760126,97525,522Apr 04 05:21 PM
HELLMAN PETER SDirectorApr 02Sale64.743,760243,40821,762Apr 04 05:21 PM
STROUCKEN ALBERT P LDirectorApr 02Sale64.753,760243,44324,620Apr 04 05:21 PM
GAVIN JAMES R IIIDirectorMar 28Option Exercise28.7918,750539,86351,388Mar 30 04:03 PM
STORM KORNELIS J.DirectorMar 28Option Exercise34.4947,9591,654,19870,471Mar 30 04:05 PM
STORM KORNELIS J.DirectorMar 28Sale64.6447,9593,100,11422,512Mar 30 04:05 PM
GAVIN JAMES R IIIDirectorMar 28Sale64.5618,7501,210,49832,638Mar 30 04:03 PM
Shapazian Carole JDirectorMar 02Option Exercise31.264,990155,98714,838Mar 05 04:06 PM
Shapazian Carole JDirectorMar 02Sale66.054,990329,5909,848Mar 05 04:06 PM
open in yahoo | open in reuters | open in google